--- title: "Zynex Enters Chapter 11 and Faces Nasdaq Delisting" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/270215954.md" description: "Zynex, Inc. filed for Chapter 11 bankruptcy on December 15, 2025, and entered a restructuring agreement with key stakeholders. A $22.3 million DIP loan was approved to fund Chapter 11 costs. Nasdaq will delist Zynex's stock due to the bankruptcy, with trading suspended on December 24, 2025. Zynex's stock is rated as 'Sell' with a $0.84 target, and the company faces financial challenges, including declining revenues and high leverage." datetime: "2025-12-18T22:13:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/270215954.md) - [en](https://longbridge.com/en/news/270215954.md) - [zh-HK](https://longbridge.com/zh-HK/news/270215954.md) --- > 支持的语言: [English](https://longbridge.com/en/news/270215954.md) | [繁體中文](https://longbridge.com/zh-HK/news/270215954.md) # Zynex Enters Chapter 11 and Faces Nasdaq Delisting ### Claim 50% Off TipRanks Premium and Invest with Confidence - Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions - Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential The latest announcement is out from Zynex ( (ZYXI) ). On December 15, 2025, Zynex, Inc. and certain subsidiaries filed for voluntary Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the Southern District of Texas and entered into a restructuring support agreement with key noteholders and debtor-in-possession (DIP) lenders to back a $22.3 million senior secured DIP term loan. The DIP Facility, approved on an interim basis on December 17, 2025, provides three milestone-based draws, carries a 10% paid-in-kind interest rate plus multiple fees and a 2.0x minimum return on invested capital, matures the earlier of 105 days after the petition date, acceleration upon default, or a sale of substantially all assets, and is secured by a priming lien on virtually all of the company’s assets to fund Chapter 11 costs and ongoing working capital. Also on December 17, 2025, Nasdaq notified Zynex that it would delist the company’s common stock due to the Chapter 11 filings, with trading to be suspended on December 24, 2025 and a Form 25-NSE to be filed; Zynex does not plan to appeal and expects its shares may trade on an OTC Markets venue, while warning that trading in its securities during the bankruptcy is highly speculative and that equity holders are likely to incur significant losses under the contemplated restructuring. The most recent analyst rating on (ZYXI) stock is a Sell with a $0.84 price target. To see the full list of analyst forecasts on Zynex stock, see the ZYXI Stock Forecast page. **Spark’s Take on ZYXI Stock** According to Spark, TipRanks’ AI Analyst, ZYXI is a Underperform. Zynex’s overall stock score is significantly impacted by its poor financial performance, with declining revenues, high leverage, and negative equity. The technical analysis further indicates a bearish trend, while the valuation is unattractive due to a negative P/E ratio. The earnings call and corporate events highlight ongoing financial and operational challenges, despite strategic initiatives. To see Spark’s full report on ZYXI stock, click here. **More about Zynex** Zynex, Inc. is a medical technology company that develops and markets electrotherapy and pain management devices, with a focus on patients requiring non-invasive therapeutic solutions, and its securities are listed on public markets, including the Nasdaq prior to the events described. **Average Trading Volume:** 5,007,434 **Technical Sentiment Signal:** Sell **Current Market Cap:** $10.34M For a thorough assessment of ZYXI stock, go to TipRanks’ Stock Analysis page. ### 相关股票 - [Zynex (ZYXI.US)](https://longbridge.com/zh-CN/quote/ZYXI.US.md) - [ZYNEX INC (ZYXIQ.US)](https://longbridge.com/zh-CN/quote/ZYXIQ.US.md) ## 相关资讯与研究 - [17:03 ETZynex Investor Alert: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline](https://longbridge.com/zh-CN/news/278944339.md) - [Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline](https://longbridge.com/zh-CN/news/278745710.md) - [14:05 ETHagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements](https://longbridge.com/zh-CN/news/279306232.md) - [Meridian Holdings Regains Nasdaq Compliance After Reverse Split](https://longbridge.com/zh-CN/news/279613693.md) - [Nasdaq teams up with Kraken to expand tokenization infrastructure](https://longbridge.com/zh-CN/news/278404637.md)